Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid, point of care cervical cancer testing platform based on its patented biophotonic technology, announced today that it will be presenting at the 2015 Aegis Growth Conference to be held October 7-9, 2015 at...
Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today it will meet with the U.S. Food and Drug Administration (FDA) November 6, 2015, to review the company’s plan to...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that its Turkish distributor, ITEM Medical Technologies, has received an increased order for disposable Cervical...
Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that it has entered into an amendment agreement to increase by $550,000 the gross cash proceeds from its previously announced private placement of convertible preferred stock and common stock warrants, as well as...
Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that it has expanded access to the LuViva® Advanced Cervical Scan to Bulgaria, bringing to 21 the number of countries where the Company has shipped its non-invasive, point-of-care cervical cancer detection...
Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that access to the LuViva® Advanced Cervical Scan has been expanded to Costa Rica, bringing to 20 the number of countries where the Company has shipped its non-invasive, point-of-care cervical cancer detection...
